- Previous Close
0.3650 - Open
0.3650 - Bid 0.3650 x --
- Ask 0.4100 x --
- Day's Range
0.3650 - 0.4100 - 52 Week Range
0.0007 - 1.0000 - Volume
509 - Avg. Volume
4,949 - Market Cap (intraday)
18.143M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. The company is based in Toronto, Canada.
conavi.comRecent News: CNVIF
View MorePerformance Overview: CNVIF
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNVIF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNVIF
View MoreValuation Measures
Market Cap
16.08M
Enterprise Value
26.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-98.23%
Return on Equity (ttm)
--
Revenue (ttm)
2.16M
Net Income Avi to Common (ttm)
-43.62M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
436k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-16.88M